Silo Pharma (NASDAQ:SILO) Posts Quarterly Earnings Results

Silo Pharma (NASDAQ:SILO) issued its quarterly earnings results on Friday. The company reported ($0.41) earnings per share for the quarter, Zacks reports. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%.

Silo Pharma Stock Performance

Shares of SILO stock opened at $1.25 on Friday. Silo Pharma has a twelve month low of $0.77 and a twelve month high of $4.50. The business has a fifty day simple moving average of $1.50 and a 200 day simple moving average of $1.24.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.